3521 - 3530 of 6570 Results
Title
Year
-
OPENTitle: The future of clinical trials? Monitoring mobility as an outcome measure in Parkinson's disease: The mobilise-D studyJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 16Issue #: 1Start Page: 110End Page: 124Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/1877718x251407026Best OA location URL: https://doi.org/10.1177/1877718x251407026Citation Count: 4
- In Situ Global Structural Proteome Analysis Identifies Potential Biomarkers for Parkinson's Disease2023OPENTitle: In Situ Global Structural Proteome Analysis Identifies Potential Biomarkers for Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 2Start Page: 198End Page: 198Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29315Best OA location URL: https://doi.org/10.1002/mds.29315Citation Count: 2
-
OPENTitle: Dissecting the Binding Profile of PET Tracers to Corticobasal Degeneration Tau FibrilsJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 12Issue #: 18Start Page: 3487End Page: 3496Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.1c00536Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.1c00536Citation Count: 24
-
OPENTitle: Impaired contrast sensitivity is associated with more severe cognitive impairment in Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 34Issue #:Start Page: 15End Page: 19Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2016.10.006Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5222688Citation Count: 40
-
OPENTitle: A high-content imaging workflow to screen for molecules that reduce cellular uptake of α-synuclein preformed fibrilsJournal Name: MethodsPublisher: Elsevier BVVol: 252Issue #:Start Page: 41End Page: 54Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ymeth.2026.05.001Best OA location URL: https://doi.org/10.1016/j.ymeth.2026.05.001Citation Count: 0
-
OPENTitle: Fyn Knock-Down Prevents Levodopa-Induced Dyskinesia in a Mouse Model of Parkinson’s DiseaseJournal Name: eneuroPublisher: Society for NeuroscienceVol: 8Issue #: 4Start Page: ENEURO.0559End Page: 20.2021Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1523/eneuro.0559-20.2021Best OA location URL: https://www.eneuro.org/content/eneuro/8/4/ENEURO.0559-20.2021.full.pdfCitation Count: 14
-
OPENTitle: Targeting Rab‐RILPL interactions as a strategy to downregulate pathogenic LRRK2 in Parkinson's diseaseJournal Name: Journal of Peptide SciencePublisher: WileyVol: 30Issue #: 5Start Page: e3563End Page: e3563Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/psc.3563Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/psc.3563Citation Count: 4
-
OPENTitle: Testing the Protein Propagation Hypothesis of Parkinson DiseaseJournal Name: Journal of Experimental NeurosciencePublisher: SAGE PublicationsVol: 12Issue #:Start Page: 1179069518786715End Page: 1179069518786715Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/1179069518786715Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/1179069518786715Citation Count: 33
-
OPENTitle: A comprehensive cognitive analysis of cervical dystonia: A single centre studyJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 9Issue #:Start Page: 100226End Page: 100226Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2023.100226Best OA location URL: https://doi.org/10.1016/j.prdoa.2023.100226Citation Count: 3
- The challenges of experimental pharmacology in identifying novel treatments for Parkinson's disease2026OPENTitle: The challenges of experimental pharmacology in identifying novel treatments for Parkinson's diseaseJournal Name: Current Opinion in NeurobiologyPublisher: Elsevier BVVol: 97Issue #:Start Page: 103164End Page: 103164Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.conb.2025.103164Best OA location URL: https://doi.org/10.1016/j.conb.2025.103164Citation Count: 2